Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
IJKD-Iranian Journal of Kidney Diseases. 2010; 4 (3): 232-236
em Inglês | IMEMR | ID: emr-97780

RESUMO

Oral hygiene in kidney transplant recipients contributes to maintenance of the transplanted organ and its function. Thus, an investigation of oral lesions could be counted as a notable work. These patients have the potential to be involved with lesions developed as a result of the administration of immunosuppressive drugs. The aim of this study was to investigate oral lesions in a group of kidney transplant recipients. The present study was a cross-sectional research on 100 patients with a kidney transplant for at least 3 months. Oral mucosa was assessed clinically for any lesion. Additional data on systemic diseases, transplant duration, and medications were recorded. Twenty-four percent of the patients had at least 1 oral lesion. The most common lesion was oral candidiasis in 16% of the participants [13 cases of acute pseudomembranous and 3 cases of chronic oral candidiasis]. Gingival enlargement was seen in 7% of the kidney transplant recipients, and 2% had a coated tongue. Elimination of oral fungal lesions in kidney transplant recipients is highly recommended. We hope this study can shed light on this particular aspect of healthcare in kidney transplant recipients


Assuntos
Humanos , Adolescente , Adulto , Pessoa de Meia-Idade , Idoso , Masculino , Feminino , Transplante de Rim , Candidíase Bucal/epidemiologia , Crescimento Excessivo da Gengiva/epidemiologia , Estudos Transversais
2.
Journal of Dental Research, Dental Clinics, Dental Prospects. 2007; 1 (2): 53-58
em Inglês | IMEMR | ID: emr-83350

RESUMO

Muscular pain in the facial region is the most common cause of facial pains. Myofascial pain dysfunction syndrome [MPDS] is one of the most important facial muscle disorders comprising of signs and symptoms including pain during function, tenderness in the muscles of mastication and restricted jaw movement. Due to the lack of an accepted therapeutic approach, the purpose of this paper was to find an effective treatment to decrease the pain of such patients. Considering the analgesic and anti-inflammatory action of laser therapy, the effects of low level laser [Ga-Al-As] in the treatment of MPDS patients referred to Tehran University of Medical Sciences Faculty of Dentistry, were investigated in the present study. This study was a quasi-experimental research. Twenty-two MPDS patients were selected from those referred to Department of Oral Medicine, Tehran University of Medical Sciences Faculty of Dentistry. Clinical examination was performed at six stages in the following order: prior to the treatment, at 2 and 4 weeks after treatment, and monthly thereafter for a 3-months follow-up. All patients underwent low-level laser therapy for 4 weeks [12 sessions]. Variables such as pain severity, pain of cheek region, pain frequency, tenderness of masticatory muscles, click, and mouth opening were evaluated at each stage. Numerical variables were investigated using Analysis of Variance test for repeated measures whereas ranking variables were studied by non-parametric Kruskal-Wallis test. At the end of treatment period, pain severity, pain of cheek region, pain frequency, tenderness of masseter, temporalis, medial pterygoid, and lateral pterygoid muscles showed significant improvement as compared with the commencement of any treatment which continued during the 3-months post-treatment [p < 0.05]. It was shown that low-level laser [Ga-Al-As] therapy had the efficacy to alleviate pain and decrease the tenderness of masticatory muscles among MPDS patients through a continuous and regular therapeutic program


Assuntos
Humanos , Masculino , Feminino , Terapia com Luz de Baixa Intensidade , Síndrome da Disfunção da Articulação Temporomandibular , Músculos da Mastigação , Dor , Má Oclusão , Transtornos da Articulação Temporomandibular
3.
Archives of Iranian Medicine. 2005; 8 (4): 252-256
em Inglês | IMEMR | ID: emr-176478

RESUMO

Oral lichen planus [OLP] is a chronic inflammatory disease characterized by relapses and remissions. There is currently no cure for OLP. Treatment is aimed primarily at reducing the length and severity of symptomatic outbreaks. Topical steroids are the first-choice agent for the treatment of symptomatic, active OLP. Other topical agents that have been used in cases resistant to topical steroids include retinoids, cyclosporine, and tacrolimus. Oral and topical psoralen with a low dose of UVA is effective in treating OLP of various forms, but it seems to have too many side effects. Topical application of psoralen is promising, but IS still at experimental stage. The treatment of symptomatic OLP, especially the erosive variant, represents a perplexing therapeutic challenge. Despite numerous existing remedies, there are many treatment failures

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA